H.C. Wainwright analyst Pat Trucchio reiterated a Buy rating and $5.00 price target on Oncolytics Biotech (NASDAQ: ONCY).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE